56 results on '"Crane, Christopher"'
Search Results
2. ASO Visual Abstract: Outcomes of Distal Rectal Cancer Patients Who Did Not Qualify for Watch-and-Wait—Comparison of Intersphincteric Resection Versus Abdominoperineal Resection
3. Penile-scrotal erythrodysesthesia among rectal cancer patients receiving fluoropyrimidine-based chemoradiation: a case report series
4. Comparison between pelvic MRI, CT, and PET/CT in baseline staging and radiation planning of anal squamous cell carcinoma
5. CT and cone-beam CT of ablative radiation therapy for pancreatic cancer with expert organ-at-risk contours
6. Type of recurrence is associated with disease-free survival after salvage surgery for locally recurrent rectal cancer
7. Chemo-Re-Irradiation and Salvage Surgery for Locally Recurrent Rectal Cancer
8. Ablative radiation therapy for locally advanced pancreatic cancer: techniques and results
9. Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience
10. Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality
11. Pretreatment plasma HGF as potential biomarker for susceptibility to radiation-induced liver dysfunction after radiotherapy
12. Radiotherapy with concurrent temozolomide for the management of extraneural metastases in pituitary carcinoma
13. The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Treated with Preoperative Therapy
14. Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional Experience
15. Interstitial Brachytherapy for the Treatment of Locally Recurrent Anorectal Cancer
16. Quality of life after intensity-modulated radiation therapy for anal cancer
17. Neoadjuvant Therapy is Associated with a Reduced Lymph Node Ratio in Patients with Potentially Resectable Pancreatic Cancer
18. Radiographic Tumor–Vein Interface as a Predictor of Intraoperative, Pathologic, and Oncologic Outcomes in Resectable and Borderline Resectable Pancreatic Cancer
19. Treatment Sequencing for Resectable Pancreatic Cancer: Influence of Early Metastases and Surgical Complications on Multimodality Therapy Completion and Survival
20. The Cost-Effectiveness of Neoadjuvant Chemoradiation is Superior to a Surgery-First Approach in the Treatment of Pancreatic Head Adenocarcinoma
21. A RAND/UCLA Appropriateness Study of the Management of Familial Gastric Cancer
22. Cost-effectiveness of Treatment Strategies for Pancreatic Head Adenocarcinoma and Potential Opportunities for Improvement
23. A High Positive Lymph Node Ratio is Associated with Distant Recurrence after Surgical Resection of Ampullary Carcinoma
24. Do We Need Intensity-Modulated Radiation Therapy (IMRT) Routinely in the Preoperative Setting for Rectal Cancer?
25. Stereotactic Ablative Radiation Therapy: Role in Treatment of Liver Metastases
26. Defined Clinical Classifications Are Associated with Outcome of Patients with Anatomically Resectable Pancreatic Adenocarcinoma Treated with Neoadjuvant Therapy
27. Effect of Neoadjuvant Chemoradiation and Surgical Technique on Recurrence of Localized Pancreatic Cancer
28. Survival and Quality of Life of Patients with Resected Pancreatic Adenocarcinoma Treated with Adjuvant Interferon-Based Chemoradiation: A Phase II Trial
29. Long-Term Survival and Recurrence Outcomes Following Surgery for Distal Rectal Cancer
30. Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation
31. Molecular Biomarkers Correlate with Disease-Free Survival in Patients with Anal Canal Carcinoma Treated with Chemoradiation
32. Local Excision After Preoperative Chemoradiation Results in an Equivalent Outcome to Total Mesorectal Excision in Selected Patients with T3 Rectal Cancer
33. Staging, prognostic factors, and therapy of localized rectal cancer
34. Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma
35. Extrahepatic Bile Duct Adenocarcinoma: Patients at High-Risk for Local Recurrence Treated with Surgery and Adjuvant Chemoradiation Have an Equivalent Overall Survival to Patients with Standard-Risk Treated with Surgery Alone
36. Radiotherapy for Hepatocellular Carcinoma: An Overview
37. Impact of Induction Chemotherapy and Preoperative Chemoradiotherapy on Operative Morbidity and Mortality in Patients with Locoregional Adenocarcinoma of the Stomach or Gastroesophageal Junction
38. Impact of Induction Chemotherapy and Preoperative Chemoradiotherapy on Operative Morbidity and Mortality in Patients with Locoregional Adenocarcinoma of the Stomach or Gastroesophageal Junction
39. Results of Surgical Salvage after Failed Chemoradiation Therapy for Epidermoid Carcinoma of the Anal Canal
40. Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy
41. Preoperative and adjuvant treatment of localized rectal cancer
42. Outcome After Curative Resection for Locally Recurrent Rectal Cancer
43. Borderline resectable pancreatic cancer
44. Chemoradiotherapy for gastrointestinal cancers
45. Pancreaticoduodenectomy with vascular resection: margin status and survival duration
46. Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma
47. Phase I study of concomitant gemcitabine and IMRT for patients with unresectable adenocarcinoma of the pancreatic head
48. Neoadjuvant Chemoradiotherapy for Adenocarcinoma of the Pancreas: Treatment Variables and Survival Duration
49. WR-2721 reduces intestinal toxicity from concurrent gemcitabine and radiation treatment
50. Current Approaches and Future Strategies for Pancreatic Carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.